| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
736,771 | 736,771 | 753,795 | 841,148 | 855,076 |
| Cost of Revenue
|
-619,462 | -619,462 | -635,674 | -719,315 | -723,876 |
|
Gross Profit
|
117,309 | 117,309 | 118,121 | 121,833 | 131,200 |
| Selling, General and Administrative Expenses
|
-103,938 | -103,938 | -100,777 | -103,120 | -112,153 |
| Other Income/Expense, Operating
|
0 | 0 | 252 | 36 | -10,239 |
|
Operating Income/Expenses
|
-103,938 | -103,938 | -100,525 | -103,084 | -122,392 |
|
Total Operating Profit/Loss
|
13,371 | 13,371 | 17,596 | 18,749 | 8,808 |
| Total Net Finance Income/Expense
|
6,175 | 6,175 | 6,541 | 7,623 | 3,127 |
| Net Investment Income
|
-130 | -130 | -6 | -4 | 122 |
|
Other Income/Expense, Non-Operating
|
-- | -- | -- | 0 | -2,261 |
|
Non-Operating Income/Expenses, Total
|
6,045 | 6,045 | 6,535 | 7,619 | 988 |
|
Pretax Income
|
19,416 | 19,416 | 24,131 | 26,368 | 9,796 |
|
Provision for Income Tax
|
-2,664 | -2,664 | -3,665 | -4,064 | -3,493 |
|
Net Income from Continuing Operations
|
16,752 | 16,752 | 20,466 | 22,304 | 6,303 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
16,752 | 16,752 | 20,466 | 22,304 | 6,303 |
|
Net Income after Non-Controlling/Minority Interests
|
16,752 | 16,752 | 20,466 | 22,304 | 6,303 |
|
Net Income Available to Common Stockholders
|
16,752 | 16,752 | 20,466 | 22,304 | 6,303 |
|
Diluted Net Income Available to Common Stockholders
|
16,752 | 16,752 | 20,466 | 22,304 | 6,303 |
|
Common Dividend per Share
|
0.03 | 0.03 | 0.03 | 0.03 | 0.02 |
| Basic EPS
|
0.03 | 0.03 | 0.04 | 0.04 | 0.01 |
| Diluted EPS
|
0.03 | 0.03 | 0.04 | 0.04 | 0.01 |
|
Basic Weighted Average Shares Outstanding
|
491,371.003 | 491,371.003 | 495,869.940 | 499,771.011 | 482,947.893 |
|
Diluted Weighted Average Shares Outstanding
|
491,371.003 | 491,371.003 | 495,869.940 | 499,771.011 | 482,947.893 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
13,241 | 13,241 | 17,590 | 18,745 | 6,669 |
|
EBITDA
|
30,413 | 30,413 | 32,591 | 32,484 | 18,787 |
|
Normalized EBITDA
|
31,194 | 31,194 | 34,094 | 35,216 | 20,870 |
|
Normalized Income
|
17,315 | 17,315 | 21,577 | 23,379 | 23,036 |
|
Total Unusual Items
|
781 | 781 | 1,503 | 2,732 | 2,083 |
|
Total Unusual Items Excluding Goodwill
|
781 | 781 | 1,503 | 2,732 | 2,083 |
3/31/2023 - 6/10/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade